"The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients Wi" by Javier Perez-Fernandez

Skip to main content

All Publications

Authors

Javier Perez-Fernandez, Baptist Hospital of MiamiFollow

Title

The Use of IV Vasoactive Intestinal Peptide (Aviptadil) in Patients With Critical COVID-19 Respiratory Failure: Results of a 60-Day Randomized Controlled Trial

Publication Date

2022

Content Type

Article

PubMed ID:

Additional Authors:

Additional authors and institutional affiliations

Citation

Critical Care Medicine (2022) 50(11):1545-1554

This document is currently not available here.

Find in your library

COinS